XML 42 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2016
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Assumptions Used to Calculate Fair Value of Options Granted to Employees

The fair value of stock options granted to employees during the three and nine months ended September 30, 2016 and 2015 was estimated at the date of grant using the following assumptions:

 

 

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

 

2016

 

2015

 

2016

 

2015

Risk-free interest rate

 

1.1 – 1.4%

 

1.7 – 1.9%

 

1.1 – 1.5%

 

1.5 – 1.8%

Expected dividend yield

 

0%

 

0%

 

0%

 

0%

Expected term

 

5.8 years

 

5.8 – 5.9 years

 

5.0 – 5.8 years

 

5.0 – 5.9 years

Expected volatility

 

67%

 

67%

 

67 – 69%

 

66 – 67%

 

Schedule of Recognized Stock-Based Compensation Expense

The Company recognized stock-based compensation expense during the three and nine months ended September 30, 2016 and 2015 as follows:

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

(in thousands)

 

2016

 

 

2015

 

 

2016

 

 

2015

 

Employee awards:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expense

 

$

1,596

 

 

$

2,116

 

 

$

5,268

 

 

$

6,451

 

Selling, general and administrative expense

 

 

1,663

 

 

 

1,565

 

 

 

6,100

 

 

 

5,519

 

Stock-based compensation expense for

   employee awards

 

 

3,259

 

 

 

3,681

 

 

 

11,368

 

 

 

11,970

 

Stock-based compensation expense for

   non-employee awards

 

 

 

 

 

9

 

 

 

1

 

 

 

57

 

Less: stock-based compensation expense

  capitalized to inventory

 

 

(88

)

 

 

 

 

 

(308

)

 

 

 

Total stock-based compensation expense

 

$

3,171

 

 

$

3,690

 

 

$

11,061

 

 

$

12,027

 

 

Summary of Stock Option Activity

The following table summarizes stock option activity during the nine months ended September 30, 2016:

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average

Remaining

 

 

Aggregate

 

(in thousands, except per share amounts)

 

Options

 

 

Weighted-Average

Exercise Price

 

 

Contractual Term

(in years)

 

 

Intrinsic

Value

 

Outstanding at December 31, 2015

 

 

19,211

 

 

$

5.72

 

 

 

6.24

 

 

$

47,963

 

Granted

 

 

4,189

 

 

$

5.57

 

 

 

 

 

 

 

 

 

Exercised

 

 

(1,196

)

 

$

3.37

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(1,204

)

 

$

6.89

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2016

 

 

21,000

 

 

$

5.76

 

 

 

6.01

 

 

$

26,505

 

Vested and expected to vest at September 30, 2016

 

 

20,658

 

 

$

5.75

 

 

 

5.96

 

 

$

26,271

 

Exercisable at September 30, 2016

 

 

15,691

 

 

$

5.40

 

 

 

5.14

 

 

$

23,323